GLP-1 Drugs Linked to Reduced Cancer Risk, Researchers Say

Doctors Say These Drugs May Reduce Cancer Risk 59% More Than Diet and Exercise

New research suggests that GLP-1s may lower the risk of obesity-related cancer. Experts have theories about what's behind the association.

GLP-1 drugs linked to reduced cancer risk, researchers say

New research suggests GLP-1 drugs best known as weight loss and diabetes medications may also reduce the risk of developing certain cancers.RELATED STORY | Scientists say GLP-1s improved male testosterone levels and sperm countMultiple studies have found that people who take GLP-1 drugs may have a lower risk of developing cancer. Other studies suggest the drugs may also slow cancer progression, potentially reducing the risk of a patient reaching…

GLP-1 drugs linked to major drop in pancreatic, colorectal cancer risk - Health Care Today

The use of GLP-1 medications such as Ozempic and Wegovy for weight loss has been increasing. Researchers continue to examine how GLP-1s might affect a person’s health beyond type 2 diabetes management and weight loss. A new study found a potential link between taking GLP-1 medications and a decrease in the overall risk of developing obesity-related cancers in people without diabetes. As interest in GLP-1s continues to grow, researchers are begi…